Journal
HAEMATOLOGICA
Volume 98, Issue 7, Pages E78-E79Publisher
FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2012.083006
Keywords
omacetaxine; homoharringtonine; advanced chronic myeloid leukemia; tyrosine kinase inhibitors; imatinib; dasatinib; nilotinib